During a recent government meeting, officials outlined a regulatory framework for the cultivation and distribution of natural medicine, specifically focusing on psychedelic mushrooms. The discussion highlighted four distinct land uses associated with this emerging sector.

The first category is cultivation facilities, which will be responsible for growing the approved natural medicine products. Currently, only two specific substances are permitted for cultivation, contrasting with an earlier proposal that included five.

The second category involves product manufacturers, who will process the cultivated products into various forms such as capsules and powders. Visual aids were presented to illustrate what these facilities might look like, emphasizing the controlled environments necessary for cultivation.

Testing facilities represent the third category, designed to ensure the safety and efficacy of the products consumed by individuals over the age of 21. These laboratories will operate independently from cultivation and manufacturing sites to avoid conflicts of interest.

Finally, the meeting addressed healing centers, where individuals can consume the natural medicine products. These centers will facilitate a structured experience, including preparation, administration, and post-consumption integration sessions, akin to therapeutic environments.

The term \"natural medicine\" was clarified during the meeting, specifically referring to psychedelic mushrooms in this context, distinguishing it from other forms of alternative medicine. This regulatory framework marks a significant step in the state's approach to natural medicine, reflecting a growing acceptance and structured oversight of psychedelic substances.